AngioDynamics (NASDAQ:ANGO – Free Report) had its price target cut by HC Wainwright from $20.00 to $18.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q3 2024 earnings at ($0.12) EPS, Q4 2024 earnings at […]
AngioDynamics (NASDAQ:ANGO) Releases FY24 Earnings Guidance kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share guidance of -0.420–0.350 for the period, compared to the consensus earnings per share estimate of -0.320. The company issued revenue guidance of $320.0 million-$325.0 million, compared to the consensus revenue estimate of $329.1 million. AngioDynamics […]
AngioDynamics (NASDAQ:ANGO – Get Free Report) issued an update on its second quarter earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of ($0.05) for the period, compared to the consensus estimate of ($0.08). The company issued revenue guidance of $79.1 million, compared to the consensus revenue estimate of $81.95 million. […]
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Analysts at HC Wainwright reduced their Q2 2024 earnings estimates for shares of AngioDynamics in a research report issued to clients and investors on Thursday, October 5th. HC Wainwright analyst Y. Chen now anticipates that the medical instruments supplier will post earnings of ($0.08) per share for the […]